Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

Clinical trial NCT05836571 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05836571
Sponsor: National Cancer Institute LAO
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Extraskeletal Myxoid Chondrosarcoma Locally Advanced Leiomyosarcoma Locally Advanced Liposarcoma Locally Advanced Undifferentiated Pleomorphic Sarcoma Locally Advanced Unresectable Soft Tissue Sarcoma Metastatic Soft Tissue Sarcoma Metastatic Undifferentiated Pleomorphic Sarcoma Unresectable Leiomyosarcoma Unresectable Liposarcoma Unresectable Undifferentiated Pleomorphic Sarcoma

Start date: 2023-10-25
Primary completion: 2026-05-15
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.